Navigation Links
SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
Date:7/15/2013

SACRAMENTO, Calif., July 15, 2013 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of medical systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and other tissues, announced today that it has been granted FDA 510(k) clearance to market its three related products to process cord blood:

  • SynGenXTM-1000 System: A programmable Control Module, Docking Station and Disposable Cartridge for harvesting stem and progenitor cells from units of collected cord blood. These cells are used to reconstitute the hematopoietic system of patients afflicted with hematologic malignancies such as leukemia and lymphoma and more than 70 genetic diseases.
  • CryoPRO-2TM Cryopreservation/Storage Bag Set: A disposable processing set with a chamber into which the harvested stem and progenitor cells from the SynGenXTM-1000 are transferred, mixed with cryoprotectant and transferred under sterile conditions into a multiple compartment bag for freezing and storage at liquid nitrogen temperatures (-196o C).
  • SynGen™ DataTrak software: The application code that provides the interface between the operator and the SynGenX™-1000 System through a host PC computer. It downloads processing and system information from the SynGenX™-1000 Control Module and stores it in a database on the host PC computer.

Earlier, the Company was awarded an ISO 13485:2003 Certificate of Registration and a Full Quality Assurance certificate by the British Standards Institution (BSI), which allows it to CE mark its own Class 1 products and commercialize them in the European Union (EU).

Philip Coelho, SynGen's CEO noted: "We thank the FDA for guiding us through the 510(k) clearance process. SynGen is dedicated to developing products
'/>"/>

SOURCE SynGen Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
2. Bison Stainless Tube Receives ISO 9001:2008 Certification
3. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
4. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
5. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
6. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
7. Micell Technologies Receives CE Mark Approval for MiStent SES
8. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
9. KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
10. ViroPharma Receives Orphan Drug Designation For Maribavir In Europe
11. Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014 In ... a product,s web presence to reflect the needs ... in particular, must meet the needs of key ... culture. According to recent research ... half of the participating companies averaged more than ...
(Date:12/19/2014)... 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch America" ... to provide this review of the Company,s recent achievements ... "Over this past year, we achieved many of ... proud to say that Monarch America is in a ... ever been," stated Eric Hagen , CEO of ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... 2007--Sciele Pharma, Inc.,(NASDAQ:SCRX) today announced the successful completion ... formulation. The study,results showed that the new Sular ... new Sular formulation,utilizes SkyePharma's (LSE:SKP) patented Geomatrix technology,which ... Sular for each of its,current doses. , The ...
... Calif.--(BUSINESS WIRE)--May 14, 2007 - Oculus Innovative,Sciences, ... was the subject of a poster presentation ... that was held in,Glasgow, Scotland this past ... an Antimicrobial,Solution in the Treatment of Infected ...
Cached Medicine Technology:Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 2Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 3Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 4Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3
(Date:12/19/2014)... These vanadium reserves are mostly found ... 151,000 tons of vanadium were produced globally in 2013, ... increased at 6.7% AAGR during the period from 2001 ... being the largest consumer, accounted for more than 90% ... alloy and the chemical industry. , View Full Report ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Injectable drug ... double the suicide attempt rate of other substance users, ... use is associated with the risk of suicide attempt ... the University of Montreal, said in a university news ... users. We wanted to know who among substance users ...
(Date:12/19/2014)... NC (PRWEB) December 19, 2014 Surviving Mesothelioma ... and EPA information indicates that these pipes can leach asbestos ... go to the full story on the Surviving Mesothelioma ... the erosion of natural asbestos deposits, decaying water mains made ... drinking water. , To protect consumers from mesothelioma ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Memorial Hospital in Franklin, Ind. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... full service hospital providing care to the residents of ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
... along with commonly used medications may help ease ... for breast cancer patients, if researchers at National ... , , ,According to Dr. Joannieshen MD, MPH, ... in controlling vomiting than just medication.Ian Cyrus, Director ...
... children of a lesser God. The physical, mental, moral ... One stumbling handicap in the surgical treatment of such ... children. In many cases the anesthesia times ranged from ... placement to hemispherectomy. There is however light at ...
... heart attack patients should get an immediate procedures to open ... ,Cleveland Clinic cardiologist, Dr. Deepak Bhatt analyzed medical records ... patients whose white blood cell count is in what is ... of death after a heart attack than patients with lower ...
... uncommon problem due to the hot and often humid weather. Most ... The cause of stone disease is debatable, however it is ... stone disease. , ,New research by the National Kidney ... Nano bacteria., ,These bacteria use a protective covering made of ...
... 8-center study by "Childhood Asthma Management Program" (CAMP) has ... the long-term treatment of children with mild to moderate ... the effectiveness of inhaled corticosteroids in treating asthma, their ... questions have been raised about their possible effects on ...
... and many a times the diagnosis is made by ... a promising technique for early diagnosis of Urinary Tuberculosis. ... amplification of small amounts of a genome sequence, Dr ... Congress in India. Presence of even one bacteria can ...
Cached Medicine News:Health News:Inhaled Steroids Safe & Effective for Children with Asthma 2
Full Handle Laseredge Slit Blade Knife, 3.0 mm straight. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Full Handle Laseredge Slit Blade Knife, 2.65 mm angled bevel up. Blade tip dimension: 14.4 mm x 2.65 mm x 3.7 mm....
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip. Blade dimension: 14.4 mm x 3.2 mm x 3.8 mm x 1.65 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Medicine Products: